Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions.
about
Human Vascular Microphysiological System for in vitro Drug Screening.Alcohol-free red wine prevents arterial thrombosis in dietary-induced hypercholesterolemic rats: experimental support for the 'French paradox'ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1.Effect of a plant sterol-enriched spread on biomarkers of endothelial dysfunction and low-grade inflammation in hypercholesterolaemic subjectsVariable reactive hyperemia in normotensive strains of ratThe pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes.Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.Association of serum lipid levels with diabetic retinopathy.Evaluation of the Serum Levels of Nitric Oxide among Diabetic Patients and its Correlation with Lipid Profile as well as Oxidative Stress in North Indian Setting.Pathogenesis of atherosclerosis: A multifactorial process.Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis.Modulation of thrombomodulin-dependent activation of human protein C through differential expression of endothelial Smads.Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.Influence of serum lipids on the incidence and progression of diabetic retinopathy and macular oedema: Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular genetics Study-II.Genetic disruption of multidrug resistance-associated protein 1 improves endothelial function and attenuates atherosclerosis in MRP1-/- LDLr-/- double knockout mice.Association of serum lipids with diabetic retinopathy in type 2 diabetes.Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study.Pilot study examining the effect of cholesterol lowering on platelet nitric oxide responsiveness and arterial stiffness in subjects with isolated mild hypercholesterolaemia.HMG-CoA reductase inhibitor attenuates platelet adhesion in intestinal venules of hypercholesterolemic mice.Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine.Endothelial damage and hemostatic markers in patients with uncomplicated mild-to-moderate hypertension and relationship with risk factors.The role of endoplasmic reticulum stress in endothelial dysfunction induced by homocysteine thiolactone.Type 1 diabetes and hypercholesterolaemia reveal the contribution of endothelium-derived hyperpolarizing factor to endothelium-dependent relaxation of the rat aorta.Decreased serum L-arginine and L-citrulline levels in major depression.Impact of metabolic control on macular thickness in diabetic macular oedema.Hypercholesterolemia-Induced Loss of Flow-Induced Vasodilation and Lesion Formation in Apolipoprotein E-Deficient Mice Critically Depend on Inwardly Rectifying K+ Channels.Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatmentRelationship between dyslipidemia and diabetic retinopathy: A systematic review and meta-analysis
P2860
Q27346581-4FB4AD16-FB56-4AD5-8445-B3D1D51C435AQ28568870-861D5B6E-D834-446A-85FF-7553890E77CCQ30574383-C9B3DCF8-B0E2-45E2-ABA0-FA29CD2E0E35Q33782212-3B58C8CC-2F7B-46C3-B15C-96E9B490D8DEQ34400004-B06646B7-0F1E-432A-A28A-264D778D3534Q36165860-986EAA16-5BE5-4104-A4D7-859779C9D59BQ36192169-2E54269F-49EC-4251-BB4E-E10648C03A6AQ36342643-C0E4A2FF-25E1-4D2E-80AA-C9EAD08B6F01Q36955743-54B8BC44-4FF5-4A9D-AFE3-710F40272F10Q37102765-6F3D129C-E138-4F43-93C1-EB9D893C1EC4Q37276377-6D95486F-D81A-41FB-9B96-94D36F4A6331Q38295438-10640955-2DB1-4965-87EC-89F45519B05DQ38361465-40E4C273-9DA6-4C1A-83F2-2F719E078772Q38773916-B2CB7F81-F6EB-4056-807A-059FFC019DD2Q40198580-42A5C327-18E6-40E4-B2C8-0CE9B9687B98Q41015232-4C577501-6E99-41A5-91EB-61998AEC334CQ41874907-9FF22741-00DC-4181-8352-6A9A5A8905EDQ42966053-5C14097D-6C53-4569-BF96-C19C0AE1825CQ44489027-6C833539-A15C-4E96-BC6E-C94B0ECB4762Q44704956-0210F960-B93F-4192-A466-C63D7A47C1B5Q45161114-2732575A-5E09-4199-AF4C-4792AF037C02Q46431030-F253FC0E-51A1-44FE-8FAF-398891CC5F93Q46781956-EA56C9BC-7501-4C2B-897E-F5D63C802E7EQ46946120-E438DB4B-02F2-4768-984B-693ABC613CF7Q47799364-AF59E4AF-3D2C-4595-B4FE-B6BAEC1C68B2Q48166322-C3768E09-98BF-49D6-B792-FAF5C3A619F4Q51744807-ABC261D8-FB1E-43F5-940B-D48E9DCFA58EQ56906572-F7793E4A-8756-4A52-A5EE-EFF4B1B43633Q58759301-1F1F96CF-C405-4E94-9956-774D13573AB7
P2860
Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Endothelial dysfunction in hyp ...... and therapeutic interventions.
@ast
Endothelial dysfunction in hyp ...... and therapeutic interventions.
@en
Endothelial dysfunction in hyp ...... and therapeutic interventions.
@nl
type
label
Endothelial dysfunction in hyp ...... and therapeutic interventions.
@ast
Endothelial dysfunction in hyp ...... and therapeutic interventions.
@en
Endothelial dysfunction in hyp ...... and therapeutic interventions.
@nl
prefLabel
Endothelial dysfunction in hyp ...... and therapeutic interventions.
@ast
Endothelial dysfunction in hyp ...... and therapeutic interventions.
@en
Endothelial dysfunction in hyp ...... and therapeutic interventions.
@nl
P2093
P921
P356
P1476
Endothelial dysfunction in hyp ...... and therapeutic interventions.
@en
P2093
P304
P356
10.1055/S-2000-13209
P577
2000-01-01T00:00:00Z